Ji Xingyu, Chairman of Meilan Biology, was invited to participate in the Henan University Students' Homecoming Entrepreneurship Symposium

Zhang Yizhen, deputy director of the Ministry of Human Resources and Social Security, Liu Shiwei, deputy director of the Provincial Department of Human Resources and Social Security, and Li Zhen, deputy director of the Provincial Department of Human Resources and Social Security, held a symposium on the return of college students to their hometown for entrepreneurship and the introduction of high-level talents from enterprises in Henan Province at the Zijingshan Hotel in Zhengzhou.

Ji Xingyu, chairman of AXA Pharmaceutical, was invited to participate in the symposium.

Chairman Ji Xingyu reported to Minister Zhang that the key factor for the rapid development of AXA Pharmaceutical at a rate of no less than 60% every year in recent years was to strengthen the introduction of high-tech talents, product technology upgrading and technological innovation, which was highly recognized by Minister Zhang. We believe that our company is a young and dynamic high-tech biomedical company. We must seize the opportunity, focus on high-tech talents, strengthen the core role of scientific and technological innovation in the development of the enterprise, and strive to build the enterprise into a modern high-tech enterprise.

Ji Xingyu, the chairman of the board, said that he must keep in mind the guidance and instructions of Minister Zhang, never forget his original intention, manage the company well and maintain the momentum of high-speed discovery of the company!

God bless China and prosper China

Since its establishment in 2005, AXA Pharmaceutical has been increasing investment in scientific and technological innovation and product research and development. The company has 2 doctors and 12 masters. The company now has more than 20 patents for veterinary medicine and vaccine invention, more than 20 provincial scientific and technological achievements, and more than 10 new veterinary drugs under research.

One hundred years to do one thing well

Escort the healthy development of China's aquaculture industry

After a long period of accumulation and precipitation, the "Meilan Biological" vaccine factory of AXA Pharmaceutical has successfully passed the GMP static and dynamic acceptance of the Ministry of Agriculture, and the product will soon be put on the market, in order to thank customers and dealers for their support and love over the years. From now on, AXA Pharmaceuticals will start the recruitment of vaccine management rights. AXA Pharmaceuticals will work with customers and dealers from all over the country to sincerely cooperate and forge ahead to jointly escort the healthy development of China's veterinary medicine industry.